Michelle L. Tas

426 total citations
4 papers, 78 citations indexed

About

Michelle L. Tas is a scholar working on Neurology, Oncology and Cancer Research. According to data from OpenAlex, Michelle L. Tas has authored 4 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 4 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Michelle L. Tas's work include Neuroblastoma Research and Treatments (4 papers), Lung Cancer Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Michelle L. Tas is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Lung Cancer Research Studies (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Michelle L. Tas collaborates with scholars based in Netherlands and United States. Michelle L. Tas's co-authors include Max M. van Noesel, Kathelijne C.J.M. Kraal, Godelieve A.M. Tytgat, Bart de Keizer, Miranda P. Dierselhuis, Ardine Reedijk, Henrike E. Karim‐Kos, Leontien C.M. Kremer, Natasha K. A. van Eijkelenburg and Geert O. Janssens and has published in prestigious journals such as European Journal of Cancer, Cancers and Pediatric Blood & Cancer.

In The Last Decade

Michelle L. Tas

4 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle L. Tas Netherlands	4	68	25	24	16	11	4	78
Matthew Gianferante United States	3	58 0.9×	34 1.4×	23 1.0×	23 1.4×	15 1.4×	4	81
Anne Guimier France	6	23 0.3×	42 1.7×	16 0.7×	12 0.8×	6 0.5×	14	84
Illja J. Diets Netherlands	7	36 0.5×	36 1.4×	6 0.3×	31 1.9×	13 1.2×	8	113
Lorena Baroni Argentina	7	46 0.7×	18 0.7×	10 0.4×	13 0.8×	5 0.5×	16	103
Pietro Businaro Italy	8	147 2.2×	38 1.5×	17 0.7×	15 0.9×	2 0.2×	15	180
Naoko Takebe United States	6	17 0.3×	39 1.6×	16 0.7×	51 3.2×	6 0.5×	17	102
Brent Coffey United States	5	25 0.4×	18 0.7×	27 1.1×	25 1.6×	10 0.9×	11	70
Neevika Manoharan Australia	4	56 0.8×	26 1.0×	8 0.3×	6 0.4×	3 0.3×	17	109
Elen Oliveira Brazil	4	22 0.3×	24 1.0×	10 0.4×	35 2.2×	14 1.3×	5	100
Ellen Fraint United States	5	18 0.3×	44 1.8×	27 1.1×	19 1.2×	9 0.8×	13	89

Countries citing papers authored by Michelle L. Tas

Since Specialization

Citations

This map shows the geographic impact of Michelle L. Tas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle L. Tas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle L. Tas more than expected).

Fields of papers citing papers by Michelle L. Tas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle L. Tas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle L. Tas. The network helps show where Michelle L. Tas may publish in the future.

Co-authorship network of co-authors of Michelle L. Tas

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle L. Tas. A scholar is included among the top collaborators of Michelle L. Tas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle L. Tas. Michelle L. Tas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Cornel, Annelisa M., Eveline M. Delemarre, Coco de Koning, et al.. (2021). Immune Monitoring during Therapy Reveals Activitory and Regulatory Immune Responses in High-Risk Neuroblastoma. Cancers. 13(9). 2096–2096. 11 indexed citations

2.

Tas, Michelle L., Marta Fiocco, Ronald R. de Krijger, et al.. (2021). Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis. Cancers. 13(19). 4941–4941. 3 indexed citations

3.

Tas, Michelle L., Kathelijne C.J.M. Kraal, Godelieve A.M. Tytgat, et al.. (2019). Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease. Pediatric Blood & Cancer. 67(4). e28061–e28061. 16 indexed citations

4.

Tas, Michelle L., Ardine Reedijk, Henrike E. Karim‐Kos, et al.. (2019). Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma. European Journal of Cancer. 124. 47–55. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact